Duloxetine Recall: FDA Sets Second-Highest Risk Level for Antidepressants Containing Potential Carcinogen - Health.com

Submitted by Anonymous (not verified) on Tue, 12/10/2024 - 18:36

Duloxetine Recall: FDA Sets Second-Highest Risk Level for Antidepressants Containing Potential Carcinogen  Health.com